Related Experiment Video
Updated: May 2, 2026
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.6K
Genetics of eosinophilic esophagitis
Joseph D Sherrill1, Carine Blanchard
1Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Digestive Diseases (Basel, Switzerland)
|March 8, 2014
Summary
Eosinophilic esophagitis (EoE) is a complex genetic disorder. Research is identifying genetic variants and molecular pathways contributing to EoE susceptibility, despite diagnostic challenges.
Area of Science:
- Gastroenterology
- Genetics
- Immunology
Background:
- Eosinophilic esophagitis (EoE) is a complex genetic disorder characterized by eosinophilic inflammation of the esophagus.
- Epidemiological studies indicate a prevalence of 4 in 10,000, with higher rates in males and individuals of European ancestry, suggesting a genetic basis.
- EoE often aggregates in families in a non-Mendelian pattern, pointing to a complex, polygenic etiology.
Purpose of the Study:
- To review major scientific findings in the molecular and genetic landscape of EoE.
- To discuss the challenges in identifying causal variants for complex genetic disorders like EoE.
Main Methods:
- Review of genome-wide and candidate gene association studies.
- Analysis of case-control and family-based cohort designs.
- Discussion of approaches to identify disease-associated genetic variants.
Main Results:
- Significant progress has been made in identifying molecular pathways involved in EoE pathogenesis.
- Various genetic variants associated with EoE susceptibility have been discovered through diverse study designs.
- Understanding the complex genetic architecture of EoE is crucial for advancing research.
Conclusions:
- EoE is a complex polygenic disorder with a significant genetic component.
- Continued research into molecular pathways and genetic variants is essential for understanding EoE pathogenesis.
- Overcoming obstacles in variant discovery is key to advancing EoE research and treatment.
More Related Videos
Related Concept Videos
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
01:27Esophageal Achalasia
45
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
01:30Esophageal Strictures-I: Introduction
1.3K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.3K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K